SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 222 filers reported holding SEATTLE GENETICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $3,769,000 | -35.8% | 72,010 | -34.4% | 0.06% | -38.8% |
Q4 2017 | $5,875,000 | +97.7% | 109,810 | +101.1% | 0.10% | +77.6% |
Q3 2017 | $2,971,000 | +1000.4% | 54,600 | +609.1% | 0.06% | +866.7% |
Q1 2016 | $270,000 | -31.6% | 7,700 | -12.5% | 0.01% | -25.0% |
Q4 2015 | $395,000 | -24.0% | 8,800 | -18.1% | 0.01% | -20.0% |
Q2 2015 | $520,000 | -80.5% | 10,750 | -85.7% | 0.01% | -77.8% |
Q1 2015 | $2,662,000 | -73.1% | 75,290 | -75.5% | 0.04% | -73.4% |
Q4 2014 | $9,890,000 | +1641.2% | 307,800 | +1914.4% | 0.17% | +1777.8% |
Q3 2014 | $568,000 | – | 15,280 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |